These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28205255)

  • 21. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
    Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams E
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004772. PubMed ID: 24852077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals.
    Ouyang DW; Brogly SB; Lu M; Shapiro DE; Hershow RC; French AL; Leighty RM; Thompson B; Tuomala RE
    AIDS; 2010 Jan; 24(1):109-14. PubMed ID: 19926957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exclusive breastfeeding among women taking HAART for PMTCT of HIV-1 in the Kisumu Breastfeeding Study.
    Okanda JO; Borkowf CB; Girde S; Thomas TK; Lecher SL
    BMC Pediatr; 2014 Nov; 14():280. PubMed ID: 25380718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiretroviral Treatment Is Associated With Iron Deficiency in HIV-Infected Malawian Women That Is Mitigated With Supplementation, but Is Not Associated With Infant Iron Deficiency During 24 Weeks of Exclusive Breastfeeding.
    Widen EM; Bentley ME; Chasela CS; Kayira D; Flax VL; Kourtis AP; Ellington SR; Kacheche Z; Tegha G; Jamieson DJ; van der Horst CM; Allen LH; Shahab-Ferdows S; Adair LS;
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):319-28. PubMed ID: 25723140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing HIV-1 transmission in breastfed infants in low resource settings: early HIV infection and late postnatal transmission in a routine prevention of mother-to-child transmission program in Yaounde, Cameroon.
    Njom Nlend AE; Same Ekobo C; Bagfegue Ekani B; Epée Ngoue J; Tetang Ndiang S; Tchinde Toussi F; Wamba G; Ekoe T
    J Trop Pediatr; 2013 Oct; 59(5):387-92. PubMed ID: 23751253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voluntary counselling and testing (VCT) uptake, nevirapine use and infant feeding options at the University of Nigeria Teaching Hospital.
    Onah HE; Ibeziako N; Nkwo PO; Obi SN; Nwankwo TO
    J Obstet Gynaecol; 2008 Apr; 28(3):276-9. PubMed ID: 18569467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.
    Fowler MG; Coovadia H; Herron CM; Maldonado Y; Chipato T; Moodley D; Musoke P; Aizire J; Manji K; Stranix-Chibanda L; Fawzi W; Chetty V; Msweli L; Kisenge R; Brown E; Mwatha A; Eshleman SH; Richardson P; Allen M; George K; Andrew P; Zwerski S; Mofenson LM; Jackson JB;
    J Acquir Immune Defic Syndr; 2014 Mar; 65(3):366-74. PubMed ID: 24189151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perceptions of the role of maternal nutrition in HIV-positive breast-feeding women in Malawi.
    Bentley ME; Corneli AL; Piwoz E; Moses A; Nkhoma J; Tohill BC; Ahmed Y; Adair L; Jamieson DJ; van der Horst C
    J Nutr; 2005 Apr; 135(4):945-9. PubMed ID: 15795467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
    Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Kinuthia J; Njiri F; John-Stewart GC
    Antivir Ther; 2008; 13(6):799-807. PubMed ID: 18839781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda.
    Mmiro FA; Aizire J; Mwatha AK; Eshleman SH; Donnell D; Fowler MG; Nakabiito C; Musoke PM; Jackson JB; Guay LA
    J Acquir Immune Defic Syndr; 2009 Sep; 52(1):32-9. PubMed ID: 19617849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in Breast Milk Composition of HIV-Infected and HIV-Uninfected Mothers of Premature Infants: Effects of Antiretroviral Therapy.
    Fouché C; van Niekerk E; du Plessis LM
    Breastfeed Med; 2016 Nov; 11():455-460. PubMed ID: 27529566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Community-facility linkage models and maternal and infant health outcomes in Malawi's PMTCT/ART program: A cohort study.
    Herce ME; Chagomerana MB; Zalla LC; Carbone NB; Chi BH; Eliya MT; Phiri S; Topp SM; Kim MH; Wroe EB; Chilangwa C; Chinkonde J; Mofolo IA; Hosseinipour MC; Edwards JK
    PLoS Med; 2021 Sep; 18(9):e1003780. PubMed ID: 34534213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial.
    Stranix-Chibanda L; Tierney C; Sebikari D; Aizire J; Dadabhai S; Zanga A; Mukwasi-Kahari C; Vhembo T; Violari A; Theron G; Moodley D; George K; Fan B; Sommer MJ; Browning R; Mofenson LM; Shepherd J; Nelson B; Fowler MG; Siberry GK;
    PLoS One; 2021; 16(2):e0246272. PubMed ID: 33544759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxis.
    Nelson JA; Fokar A; Hudgens MG; Compliment KJ; Hawkins JT; Tegha G; Kamwendo DD; Kayira D; Mofolo IA; Kourtis AP; Jamieson DJ; Van Der Horst CM; Fiscus SA
    AIDS; 2015 Oct; 29(16):2131-8. PubMed ID: 26186128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
    Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months.
    Shetty AK; Coovadia HM; Mirochnick MM; Maldonado Y; Mofenson LM; Eshleman SH; Fleming T; Emel L; George K; Katzenstein DA; Wells J; Maponga CC; Mwatha A; Jones SA; Abdool Karim SS; Bassett MT;
    J Acquir Immune Defic Syndr; 2003 Dec; 34(5):482-90. PubMed ID: 14657758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
    Kumwenda NI; Hoover DR; Mofenson LM; Thigpen MC; Kafulafula G; Li Q; Mipando L; Nkanaunena K; Mebrahtu T; Bulterys M; Fowler MG; Taha TE
    N Engl J Med; 2008 Jul; 359(2):119-29. PubMed ID: 18525035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in Fertility at the Population Level in the Era of ART in Rural Malawi.
    McLean E; Price A; Chihana M; Kayuni N; Marston M; Koole O; Zaba B; Crampin A;
    J Acquir Immune Defic Syndr; 2017 Aug; 75(4):391-398. PubMed ID: 28653969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.